AbbVie
ABBV
#31
Rank
NZ$536.89 B
Marketcap
$303.82
Share price
-1.60%
Change (1 day)
17.27%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2023 (TTM): $5.98

According to AbbVie's latest financial reports the company's current EPS (TTM) is $6.53. In 2022 the company made an earnings per share (EPS) of $11.82 an increase over its 2021 EPS that were of $11.52.

EPS history for AbbVie from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$5.98-49.44%
2022$11.822.63%
2021$11.52125.21%
2020$5.11-45.69%
2019$9.4248.35%
2018$6.357.6%
2017$5.90-9.3%
2016$6.5015.48%
2015$5.63185.53%
2014$1.97-57.11%
2013$4.60-21.69%
2012$5.8755.73%
2011$3.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.30-49.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.05 7.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.64 47.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$25.12 284.44%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.79 19.27%๐Ÿ‡บ๐Ÿ‡ธ USA
$32.78 401.54%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.22-4.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.52-46.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.48-46.75%๐Ÿ‡บ๐Ÿ‡ธ USA